Adverse events with anti-epidermal growth factor receptor therapy mainly involve the skin. The most common cutaneous adverse event is an acneiform eruption, which occurs in more than 50% of cases. The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
A.Patrizi, F.Bianchi, I.Neri (2008). Rosaceiform eruption induced by erlotinib. DERMATOLOGIC THERAPY, 21(Suppl. 2), S43-S45 [10.1111/j.1529-8019.2008.00233.x].
Rosaceiform eruption induced by erlotinib
PATRIZI, ANNALISA;BIANCHI, FEDERICA;NERI, IRIA
2008
Abstract
Adverse events with anti-epidermal growth factor receptor therapy mainly involve the skin. The most common cutaneous adverse event is an acneiform eruption, which occurs in more than 50% of cases. The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
